Stocks Are Rallying Too Much On Vaccine News, Says This Market Expert
TOPLINE
While reports of positive data from potential coronavirus treatments have helped propel the market higher in recent months, investors are far too optimistic about a vaccine and stocks shouldn’t be rallying so much on each bit of news, warns Vital Knowledge founder Adam Crisafulli.
Markets need to be more “skeptical” about each vaccine announcement.
Angela Weiss/AFP via Getty Images
Discover more from USNewsRank
Subscribe to get the latest posts sent to your email.